| OAB0304 | Short-course rifapentine-based regimens for latent tuberculosis infection among people living with HIV who received integrase inhibitor-based antiretroviral therapy | Oral abstract session with live Q&A | Co-infections (including opportunistic infections) |
| OAB0305 | Co-infection of High-Risk Human Papillomavirus and Human T-Lymphotropic Virus-1 among women living with HIV on Antiretroviral Therapy at a Tertiary Hospital in Kenya | Oral abstract session with live Q&A | Co-infections (including opportunistic infections) |
| EPB0263 | Single cell rnaseq analysis of persons with HIV and opioid use | E-poster | Clinical issues specific to key populations |
| EPB0264 | Oropharyngeal presentation of mpox: a neglected entity? | E-poster | Clinical issues specific to key populations |
| EPB0265 | Evaluating the perceptions of PWID about long-acting MOUD, PrEP, and ART | E-poster | Clinical issues specific to key populations |
| EPB0266 | Mpox knowledge, concern, willingness to change behaviour, and seek vaccination in Australia: results of a national cross-sectional survey | E-poster | Clinical issues specific to key populations |
| EPB0267 | Factors associated with viral load suppression amongst transgender people in South Africa | E-poster | Clinical issues specific to key populations |
| EPB0268 | The role of substance use in structural heart disease among unsheltered and unstably housed women living with HIV | E-poster | Clinical issues specific to key populations |
| EPB0269 | Review of antiretroviral therapy coverage among prisoners living with HIV in 10 African countries | E-poster | Clinical issues specific to key populations |
| EPB0187 | Hypertension among people living with HIV after starting or switching to DTG, EFV, or ATV/r-based ART at Newlands Clinic, Zimbabwe | E-poster | Clinical complications of HIV and antiretroviral therapy |